Temas de la conferencia
With Adicet Bio, In8Bio, Gamma Delta Therapeutics, Lava Therapeutics, and ImCheck Therapeutics releasing clinical data from engineered and antibody-based γδT Therapy in patients; the race to market for the first allogeneic and solid tumor-targeting γδT Therapy is truly on.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/1089722-0?pid=4832
Speakers: Blake Aftab, CSO, Adicet Bio, Francesco Galimi, CMO, Adicet Bio, Sai-Wen Tang, Director, R and D Acepodia, Frank Borriello, Scientific Founder and CEO, Alloplex Biotherapeutics, and more.
Información e inscripción:
https://go.evvnt.com/1089722-2?pid=4832
Ms. Jessica Durston
CategoríasMedicina General
